SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-043869
Filing Date
2024-04-12
Accepted
2024-04-12 08:05:13
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-12

Document Format Files

Seq Description Document Type Size
1 ARS mura-ars-2023.pdf ARS 4525162
  Complete submission text file 0000950170-24-043869.txt   6234106
Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Filer) CIK: 0001971543 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-41837 | Film No.: 24840029
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)